EGFR-mutated pulmonary adenocarcinoma with concurrent PIK3CA mutation, and with acquired RET fusion and EGFR T790M mutation after afatinib therapy

被引：0

作者：

Kim, Minhye ^{[1
]}

Na, Ji Min ^{[1
]}

Lee, Gyeong-Won ^{[2
]}

Lee, Seung Jun ^{[3
]}

Kim, Jong Duk ^{[4
]}

Yang, Jung Wook ^{[5
]}

机构：

[1] Gyeonsang Natl Univ Hosp, Dept Pathol, Jinju, South Korea

[2] Gyeongsang Natl Univ, Div Hematol Oncol, Dept Internal Med, Gyeonsang Natl Univ Hosp,Coll Med, Jinju, South Korea

[3] Gyeongsang Natl Univ, Coll Med, Gyeonsang Natl Univ Hosp, Div Pulmonol & Allergy,Dept Internal Med, Jinju, South Korea

[4] Gyeonsang Natl Univ Hosp, Dept Cardiothorac Surg, Jinju, South Korea

[5] Gyeongsang Natl Univ, Coll Med, Gyeonsang Natl Univ Hosp, Dept Pathol, 79 Gangnam Ro, Jinju 52727, South Korea

来源：

JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE | 2021年 / 55卷 / 01期

关键词：

IMPACT;

D O I：

10.4132/jptm.2020.11.02

中图分类号：

R36 [病理学];

学科分类号：

100104 ;

摘要：

引用

页码：79 / 82

页数：4

共 50 条

[1] Acquired T790M resistance do afatinib in EGFR mutated lung adenocarcinoma
Miyazaki, Kunihiko
Sato, Shinya
Kodama, Takahide
Satoh, Hiroaki
Hizawa, Nobuyuki
TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX, 2016, 64 (04): : 317 - 318
[2] Acquired resistance of pulmonary adenocarcinoma to initially successful targeted therapy due to EGFR mutation T790M
Jancarikova, D.
Pesek, M.
Benesova, L.
Topolcan, O.
Holubec, L., Jr.
Minarik, M.
ANTICANCER RESEARCH, 2007, 27 (4A) : 1879 - 1882
[3] Squamous Cell Carcinoma "Transformation" Concurrent with Secondary T790M Mutation in Resistant EGFR-Mutated Adenocarcinomas
Jukna, Agita
Montanari, Gloria
Mengoli, Maria Cecilia
Cavazza, Alberto
Covi, Marisa
Barbieri, Fausto
Bertolini, Federica
Rossi, Giulio
JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (04) : E49 - E51
[4] Real Clinical Practice of Using Afatinib Therapy in NSCLC Patients with an Acquired EGFR T790M Mutation
Miyazaki, Kunihiko
Tamura, Tomohiro
Kaburagi, Takayuki
Saito, Kazuhito
Inagaki, Masaharu
Yamashita, Takaaki
Ichimura, Hideo
Nawa, Takeshi
Endo, Takeo
Hayashihara, Kenji
Kimura, Masaki
Kurishima, Koichi
Nakamura, Hiroyuki
Furukawa, Kinya
Kikuchi, Norihiro
Satoh, Hiroaki
Hizawa, Nobuyuki
ANTICANCER RESEARCH, 2018, 38 (09) : 5409 - 5415
[5] Incidence of T790M mutation in (sequential) rebiopsies in EGFR-mutated NSCLC-patients
Kuiper, J. L.
Heideman, D. A. M.
Thunnissen, E.
Paul, M. A.
van Wijk, A. W.
Postmus, P. E.
Smit, E. F.
LUNG CANCER, 2014, 85 (01) : 19 - 24
[6] Concurrent EGFR T790M Secondary Mutation and EMT in a Lung Adenocarcinoma Patient with EGFR TKI Drug Resistance
Xu, S.
Liu, X.
Liu, R.
Shi, T.
Li, X.
Zhong, D.
Wang, Y.
Chen, G.
Chen, J.
JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2201 - S2201
[7] Simultaneous Acquisition of T790M Mutation and SCLC Transformation during Targeted Therapy in EGFR-Mutated Lung Adenocarcinoma: A Rare Case Report
Yazaki, Tatsuya
Kimoto, Masanobu
Minagawa, Ayumi
Maruno, Takashi
Yamanaka, Miwa
Sonehara, Kei
Hama, Mineyuki
Nakamura, Toshitsugu
Kanda, Shintaro
Hanaoka, Masayuki
Hachiya, Tsutomu
AMERICAN JOURNAL OF CASE REPORTS, 2024, 25
[8] Clinical utility of liquid biopsy for EGFR driver, T790M mutation and EGFR amplification in plasma in patients with acquired resistance to afatinib
Oya, Yuko
Yoshida, Tatsuya
Asada, Kazuhiro
Oguri, Tetsuya
Inui, Naoki
Morikawa, Sayako
Ito, Kentaro
Kimura, Tomoki
Kunii, Eiji
Matsui, Takashi
Kubo, Akihito
Kato, Tatsuo
Abe, Takashi
Tsuda, Takeshi
Hida, Toyoaki
BMC CANCER, 2021, 21 (01)
[9] A Patient With EGFR-Mutated Lung Cancer Progressing on Erlotinib Evaluating for a T790M Mutation With Limited Tissue
Wynja, Emily
Hove, Jenna
Powell, Steven F.
ONCOLOGY-NEW YORK, 2018, 32 (10): : 499 - 500
[10] Clinical utility of liquid biopsy for EGFR driver, T790M mutation and EGFR amplification in plasma in patients with acquired resistance to afatinib
Yuko Oya
Tatsuya Yoshida
Kazuhiro Asada
Tetsuya Oguri
Naoki Inui
Sayako Morikawa
Kentaro Ito
Tomoki Kimura
Eiji Kunii
Takashi Matsui
Akihito Kubo
Tatsuo Kato
Takashi Abe
Takeshi Tsuda
Toyoaki Hida
BMC Cancer, 21

← 1 2 3 4 5 →